“Identifying Chemical Constituents and Predicting Mechanisms of Chuanzhi Tongluo Capsules in Treating Cerebral Infarction via UPLC-Q-Exactive Orbitrap-MS and Network Pharmacology”

https://pubmed.ncbi.nlm.nih.gov/38114111

This study identified 152 chemical constituents in Chuanzhi Tongluo Capsules using UPLC-Q-Exactive Orbitrap-MS and predicted its core targets and mechanism in treating cerebral infarction through network pharmacology, revealing its potential active ingredients and therapeutic pathways.